Mirikizumab (LY 3074828) is a humanised IgG4 monoclonal antibody which binds and inhibits the p19 subunit of interleukin 23 that is being developed by Eli <br><a href=http://psoriasisinchildren.ml/art/scalp-psoriasis-in-children15/>Scalp psoriasis in children</a>
Предыдущее фотоВернуться на главнуюСледующее фото